News about Global Pharma

Aurobindo Pharma's US Subsidiary Eugia to Sell Business Assets for USD 52 Million

The agreement encompasses Eugia's related assets, liabilities, and employees, as the company strategically focuses on enhancing capacities and operations in other units.

Global Pharma | 05/02/2024 | By Manvi |  1323

Gericke Announces Inauguration of its New Production Hall in Switzerland

The state-of-the-art facility marks a significant milestone in the company's commitment to meeting the growing demand for leading-edge technology in the powder processing industry.

Global Pharma | 03/02/2024 | By Manvi |  478

Biosyngen's BST02 Receives Fast Track Designation for Liver Cancer Treatment

Fast Track Designation is a special process designed to facilitate the development and expedite the review of drugs intended to treat serious or life-threatening conditions, addressing unmet medical needs.

Global Pharma | 03/02/2024 | By Manvi |  415

NeuroBo Pharmaceuticals Receives FDA Clearance for Phase 1 Trial of DA-1726 in Obesity Treatment

The company is set to commence a Phase 1 clinical trial for obesity treatment in the first half of this year.

Global Pharma | 03/02/2024 | By Manvi |  488

FM Sitharaman Unveils Transformative Healthcare Measures in Interim Budget 2024

To address structural deficiencies in the healthcare system, the budget outlines plans to set up additional medical colleges by leveraging existing hospital infrastructure under various departments.

Global Pharma | 02/02/2024 | By Manvi |  529

Nippon Express Strengthens Pharmaceutical Logistics with CEIV Pharma Certification

The certification, issued by the International Air Transport Association (IATA), attests to the high quality and standards of pharmaceutical transport.

Global Pharma | 01/02/2024 | By Manvi |  659

Kite's Yescarta CAR T-Cell Therapy Gets FDA Nod for Manufacturing Process Change

In the realm of CAR T-cell therapies, where personalized treatment is created from a patient's white blood cells, the approval marks a significant advancement.

Global Pharma | 31/01/2024 | By Manvi |  597

NeoImmuneTech's NT-I7 Receives FDA ODD for Advanced Pancreatic Cancer Treatment

Pancreatic cancer is an aggressive tumor-type associated with extremely poor prognosis.

Global Pharma | 30/01/2024 | By Manvi |  555

Alcami Strengthens Market Position with Acquisition of Pacific Pharmaceutical Services

In addition to the acquisition of PPS, Alcami is strategically expanding its central North Carolina pharma storage and service footprint with the opening of a new 65,000 square foot facility co-located near the Research Triangle Park's biotech and pharma hub.

Global Pharma | 30/01/2024 | By Manvi |  486

Jubilant Pharma Plans Strategic Exit from Sofie Biosciences

The pharmaceutical giant's wholly-owned subsidiary had previously invested USD 25 million in Sofie Biosciences in November 2020, currently holding a noteworthy 25.8 percent stake in the company.

Global Pharma | 29/01/2024 | By Manvi |  252